Drosophila tools and assays for the study of human diseases
Many of the internal organ systems of Drosophila melanogaster are functionally analogous
to those in vertebrates, including humans. Although humans and flies differ greatly in terms …
to those in vertebrates, including humans. Although humans and flies differ greatly in terms …
[HTML][HTML] TCF4-mediated Fuchs endothelial corneal dystrophy: Insights into a common trinucleotide repeat-associated disease
MP Fautsch, ED Wieben, KH Baratz… - Progress in retinal and …, 2021 - Elsevier
Fuchs endothelial corneal dystrophy (FECD) is a common cause for heritable visual loss in
the elderly. Since the first description of an association between FECD and common …
the elderly. Since the first description of an association between FECD and common …
Drosophila Heart as a Model for Cardiac Development and Diseases
A Souidi, K Jagla - Cells, 2021 - mdpi.com
The Drosophila heart, also referred to as the dorsal vessel, pumps the insect blood, the
hemolymph. The bilateral heart primordia develop from the most dorsally located …
hemolymph. The bilateral heart primordia develop from the most dorsally located …
Therapeutic potential of AntagomiR-23b for treating myotonic dystrophy
E Cerro-Herreros, I González-Martínez… - … Therapy-Nucleic Acids, 2020 - cell.com
Myotonic dystrophy type 1 (DM1) is a chronically debilitating, rare genetic disease that
originates from an expansion of a noncoding CTG repeat in the dystrophia myotonica …
originates from an expansion of a noncoding CTG repeat in the dystrophia myotonica …
[HTML][HTML] Myotonic dystrophy: candidate small molecule therapeutics
P Konieczny, E Selma-Soriano, AS Rapisarda… - Drug discovery today, 2017 - Elsevier
Highlights•Up to 34 drug candidates identified in the last few years.•Drug screening methods
available at all levels of complexity (computational to in vivo).•Translational research has …
available at all levels of complexity (computational to in vivo).•Translational research has …
Cardiac pathology in myotonic dystrophy type 1
MS Mahadevan, RS Yadava, M Mandal - International journal of …, 2021 - mdpi.com
Myotonic dystrophy type 1 (DM1), the most common muscular dystrophy affecting adults and
children, is a multi-systemic disorder affecting skeletal, cardiac, and smooth muscles as well …
children, is a multi-systemic disorder affecting skeletal, cardiac, and smooth muscles as well …
[HTML][HTML] RNA-mediated therapies in myotonic dystrophy
Highlights•RNA medicine shows promise in DM1 therapeutics by targeting toxic CUG
expansions.•Restoring function of Muscleblind-like proteins is especially important in …
expansions.•Restoring function of Muscleblind-like proteins is especially important in …
Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3′UTR RNA
Abstract Myotonic dystrophy type 1 (DM1), the most common adult muscular dystrophy, is an
autosomal dominant disorder caused by an expansion of a (CTG) n tract within the 3 …
autosomal dominant disorder caused by an expansion of a (CTG) n tract within the 3 …
Small molecules which improve pathogenesis of myotonic dystrophy type 1
M López-Morató, JD Brook… - Frontiers in neurology, 2018 - frontiersin.org
Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy in adults for which
there is currently no treatment. The pathogenesis of this autosomal dominant disorder is …
there is currently no treatment. The pathogenesis of this autosomal dominant disorder is …
Strategies to obtain encapsulation and controlled release of pentamidine in mesoporous silica nanoparticles
Pentamidine (PTM), an antiprotozoal agent used in clinics as pentamidine isethionate salt
(PTM-S), recently showed high potential also for the treatment of cancer and myotonic …
(PTM-S), recently showed high potential also for the treatment of cancer and myotonic …